Skip to main content
Log in

Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

Atosiban has been shown to be an effective tocolytic agent with a low rate of side effects during 24 to 33 weeks of gestation. Atosiban acts through selective, competitive inhibition of both oxytocin and vasopressin, so that there are reasons to assume that a tocolytic effect can also be achieved earlier in the pregnancy.

Study design

In this prospective, randomized pilot study, 20 women in the 18th through 24th week of gestation who presented at our hospital with preterm labor were treated with atosiban. In the control group 20 women received saline infusions. All patients received antibiotic therapy. A cervical cerclage was performed when indicated as was correction of the vaginal pH.

Results

The tocolytic effect began after 3–10 min (median: 6.5 min). Treatment time until the complete absence of contractions was 3–12 h (median: 7.5 h). Pregnancies were prolonged between 11.1 and 21.7 weeks (median: 15.6 weeks) in the atosiban group vs. 10.5–19.1 weeks in the control group. If well tolerated, atosiban was continued. There were no significant alterations in the routine laboratory parameters, circulation parameters, and fluid balance.

Conclusion

In summary, atosiban showed itself to be effective for tocolytic treatment for premature labor, even during 18 and 24 weeks of pregnancy, while exhibiting its known, favorable profile of side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Akerlund M (2002) Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhoea. Prog Brain Res 139:359–365

    CAS  PubMed  Google Scholar 

  2. Akerlund M, Stromberg P, Hauksson A, Andersen LF, Lyndrup J, Trojnar J et al (1987) Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 94:1040–1044

    CAS  PubMed  Google Scholar 

  3. Akerlund M, Melin P, Maggi M (1995) Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea. Adv Exp Med Biol 395:595–600

    CAS  PubMed  Google Scholar 

  4. Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP (2001) Final results of the cervical incompetence prevention randomized cerclage trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 185:1106–1112

    Article  CAS  PubMed  Google Scholar 

  5. Andersen LF, Lyndrup J, Akerlund M, Melin P (1989) Oxytocin receptor blockade: a new principle in the treatment of preterm labor? Am J Perinatol 6:196–199

    CAS  PubMed  Google Scholar 

  6. Bossmar T (1998) Treatment of preterm labor with the oxytocin and vasopressin antagonist atosiban. J Perinat Med 26:458–465

    CAS  PubMed  Google Scholar 

  7. Bossmar T, Akerlund M, Szamatowicz J, Laudanski T, Fantoni G, Maggi M (1998) Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women. Br J Obstet Gynaecol 102:907–912

    Google Scholar 

  8. Fuchs AR, Fuchs F, Husslein P, Soloff MS, Fernström MJ (1982) Oxytocin and human parturition: a dual role for oxytocin in the initiation of labor. Science 251:1396–1398

    Google Scholar 

  9. Fuchs AR, Fuchs F, Husslein P, Soloff MS (1984) Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 150:734–741

    CAS  PubMed  Google Scholar 

  10. Fuchs AR, Fuchs F, Soloff MS (1985) Oxytocin receptors in nonpregnant human uterus. J Clin Endocrinol Metab 60:37–41

    CAS  PubMed  Google Scholar 

  11. Fuchs AR, Behrens O, Maschek H, Kupsch E, Einspanier A (1998) Oxytocin and vasopressin receptors in human and uterine myomas during menstrual cycle and early pregnancy. Hum Reprod Update Sep–Oct 4:594–604

    Google Scholar 

  12. Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683

    CAS  PubMed  Google Scholar 

  13. Goldenberg RL (2002) The management of preterm labor. Obstet Gynecol 100:1020–1037

    Article  PubMed  Google Scholar 

  14. Goldenberg RL, Hauth JC, Andrews WW (2000) Intrauterine infection and preterm birth. N Engl J Med 342:1500–1507

    Article  CAS  PubMed  Google Scholar 

  15. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R et al (1994) The effect of oxytocin receptor antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 170:474

    CAS  PubMed  Google Scholar 

  16. Hack M, Fanaroff AA (1990) Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum Dev 53:193–218

    Article  Google Scholar 

  17. Harger JM (1983) Cervical cerclage: patient selection, morbidity, and success rates. Clin Perinatol 10:321–341

    CAS  PubMed  Google Scholar 

  18. Kenyon SL, Taylor DJ, Tarnow-Mordi W (2001) Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 357:989–994

    Article  CAS  PubMed  Google Scholar 

  19. Kimura T, Azuma C, Saji F et al (1992) Estimation by an electrophysiological method of the expression of oxytocin receptor mRNA in human myometrium during pregnancy. J Steroid Biochem Mol Biol 42:253–258

    Article  CAS  PubMed  Google Scholar 

  20. Kimura T, Takemura M, Nomura S et al (1996) Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 137:780–785

    Article  CAS  PubMed  Google Scholar 

  21. King J, Flenady V (2000) Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev 2:CD000246

    PubMed  Google Scholar 

  22. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M et al (2000) Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 182:1191–1199

    Article  CAS  PubMed  Google Scholar 

  23. Novy MJ, Gupta A, Wothe DD, Gupta S, Kennedy KA, Gravett MG (2001) Cervical cerclage in the second trimester of pregnancy: a historical cohort study. Am J Obstet Gynecol 184:1447–1456

    Article  CAS  PubMed  Google Scholar 

  24. Owen J, Iams JD, Hauth JC (2003) Vaginal sonography and cervical incompetence. Am J Obstet Gynecol 188:586–596

    Article  PubMed  Google Scholar 

  25. Quinones-Jenab V, Jenab S, Ogawa S, Adan RA, Burbach JP, Pfaff DW (1997) Effects of estrogen on oxytocin receptor messenger ribonucleic acid expression in the uterus, pituitary, and forebrain of the female rat. Neuroendocrinology 65:9–17

    CAS  PubMed  Google Scholar 

  26. Rezapour M, Backstrom T, Ulmsten U (1996) Myometrial steroid concentration and oxytocin receptor density in parturient women at term. Steroids 61:338–344

    Article  CAS  PubMed  Google Scholar 

  27. Richter ON, Tschubel K, Schmolling J, Kupka M, Ulrich U, Wardelmann E (2003) Immunohistochemical reactivity of myometrial oxytocin receptor in extracorporeal perfused non-pregnant human uteri. Arch Gynecol Obstet 269:16–24

    Article  CAS  PubMed  Google Scholar 

  28. Robinson RS, Mann GE, Lamming GE, Wathes DC (1999) The effect of pregnancy on the expression of uterine oxytocin, oestrogen and progesterone receptors during early pregnancy in the cow. J Endocrinol 160:21–33

    CAS  PubMed  Google Scholar 

  29. Robinson RS, Mann GE, Lamming GE, Wathes DC (2001) Expression of oxytocin, oestrogen and progesterone receptors in uterine biopsy samples throughout the oestrous cycle and early pregnancy in cows. Reproduction 122:965–979

    Article  CAS  PubMed  Google Scholar 

  30. Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM (1994) The preterm labor syndrome. Ann NY Acad Sci 734:414–429

    CAS  PubMed  Google Scholar 

  31. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B et al (2000) An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 182:1173–1183

    Article  CAS  PubMed  Google Scholar 

  32. Rust OA, Atlas RO, Reed J, van Gaalen J, Balducci J (2001) Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage may not help. Am J Obstet Gynecol 185:1098–1105

    Article  CAS  PubMed  Google Scholar 

  33. Starbuck GR, Stout TA, Lamming GE, Allen WR, Flint AP (1998) Endometrial oxytocin receptor and uterine prostaglandin secretion in mares during the oestrous cycle and early pregnancy. J Reprod Fertil 113:173–179

    Article  CAS  PubMed  Google Scholar 

  34. Thomsen AC, Morup L, Hansen KB (1987) Antibiotic elimination of group B streptococci in urine in prevenetion of preterm labour. Lancet 1:591–593

    Article  CAS  PubMed  Google Scholar 

  35. Thornton S, Vatish M, Slater D (2001) Oxytocin antagonists: clinical and scientific considerations. Exp Physiol 86:297–302

    Article  CAS  PubMed  Google Scholar 

  36. Thorp JM, Hartmann KE, Berkman ND, Carey TS, Lohr KN, Gavin NI et al (2002) Antibiotic therapy for the treatment of preterm labor: a review of the evidence. Am J Obstet Gynecol 186:587–592

    Article  CAS  PubMed  Google Scholar 

  37. Valentin L, Slakevicius P, Kindahl H, Broeders A, Marsal K, Melin P (2000) Effects of a vasopressin antagonist in women with dysmenorrhoea. Gynecol Obstet Invest 50:170–177

    Article  CAS  PubMed  Google Scholar 

  38. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L et al (2000) Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 182:1184–1190

    Article  CAS  PubMed  Google Scholar 

  39. Watts DH, Krohn MA, Hillier SL, Eschenbach DA (1994) Randomized trial of antibiotics in addition to tocolytic therapy to treat preterm labor. Infect Dis Obstet Gynecol 1:220–227

    Google Scholar 

  40. Worldwide Atosiban Versus Beta-agonists Study Group (2001) Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labor. Br J Obstet Gynaecol 108:133–142

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oliver N. Richter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richter, O.N., Dorn, C., van de Vondel, P. et al. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy. Arch Gynecol Obstet 272, 26–30 (2005). https://doi.org/10.1007/s00404-004-0652-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-004-0652-8

Keywords

Navigation